InvestorsHub Logo
Followers 737
Posts 75842
Boards Moderated 0
Alias Born 01/01/2012

Re: PhenixBleu post# 183848

Tuesday, 02/25/2020 12:09:46 PM

Tuesday, February 25, 2020 12:09:46 PM

Post# of 203912
Hirsch certainly isn't busy taking care of OWCP - he is a part-timer.

Hirsch was with OWCP when the toxic SPA was signed - if Hirsch is so well connected why couldn't he obtain conventional financing that wasn't toxic.

Damn, Hirsch has been Chairman since 2017!

"PETACH TIKVA, Israel, July 25, 2017 /PRNewswire/ --

OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ("OWC" or the "Company"), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced the appointment of Dr. Stanley Hirsch as its active chairman of the board of directors."

The S-1 for DGF was filed on June 14, 2018.

Hirsch had been the Chairman of OWCP for a year - but he didn't help on the financing.

IG


"The Hour Between Dog and Wolf"